CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Income Statement [Abstract]
Revenues	$ 6,017,204	$ 5,344,976
Operating expenses
General and administrative	1,550,799	1,041,501
Rent expense	1,304,127	614,793
Management fees		368,003
Professional fees	955,801	707,413
Salaries and wages	3,072,654	2,656,267
Depreciation and amortization	466,952	498,919
Total operating expenses	7,350,333	5,886,896
Operating loss	(1,333,129)	(541,920)
Other (expense) income
Other income	110,000
Other expense	(1,160)
Gain on sale of property		2,484,172
Loss on debt extinguishment		(277,175)
Extension fee on property purchase		(140,000)
Penalty on notes and convertible notes		(34,688)
Interest income	2,292	676
Interest expense	(565,343)	(500,226)
Debt discount	(416,120)	(281,354)
Foreign exchange movements	37,523	(95,032)
Net (loss) income before income taxes	(2,165,937)	614,453
Income taxes		391,962
Net (loss) income	(2,165,937)	1,006,415
Net loss attributable to non-controlling stockholders interest	101,842	170,184
Net (loss) income attributable to Ethema Health Corporation Stockholders’	(2,064,095)	1,176,599
Preferred stock dividend		(47,225)
Net (loss) income available to common stockholders of Ethema Health Corporation	$ (2,064,095)	$ 1,129,374
Basic (loss) income per common share	$ (0.00)	$ 0.00
Diluted (loss) income per common share	$ (0.00)	$ 0.00
Weighted average common shares outstanding – Basic	5,608,835,226	3,729,053,805
Weighted average common shares outstanding – Diluted	5,608,835,226	3,903,671,684